Quantcast

Industry news that matters to you.  Learn more

Archives for May 2011

OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass

A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test. The study builds on prior research that shows accurate assessment of an ovarian mass for cancer prior to surgery can affect both treatment decisions and health outcomes for women with ovarian cancer.

Thirteen Proteomics Companies Form Proteomics Innovation Network

New England Peptide recently announced that it and twelve other product and service companies have started the global Proteomics Innovation Network to collaborate on unmet needs in drug discovery and personalized medicine.

The mission of the new proteomics network is to generate “from sample to discovery” solutions in all facets of proteomics, including expression, identification, characterization, interaction and function. Each member organization has complementary expertise, core technologies, and infrastructure to address critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring.

2011 ISB Systems Biology and P4 Medicine Symposium, Day 2

The first Institute for Systems Biology (ISB) symposium was held in 2002. Now in its 10th year, the Systems Biology and P4 Medicine conference provides a setting for some of the world’s most influential researchers who are leading the way in applying systems biology and systems theory to medicine and health care delivery.

2011 ISB Systems Biology and P4 Medicine Symposium, Day 1

The first Institute for Systems Biology (ISB) symposium was held in 2002. Now in its 10th year, the Systems Biology and P4 Medicine conference provides a setting for some of the world’s most influential researchers who are leading the way in applying systems biology and systems theory to medicine and health care delivery.

Rules-Based Medicine Partners with Institut Pasteur to Boost Innovation in Translational Research

Rules-Based Medicine (RBM) will be a collaborator on the Institut Pasteur research project Milieu Interieur (the environment within), funded through a LabEx grant from the French government. The project will rely on RBM’s TruCulture R an innovative in vitro model that preserves physiological cellular interactions, to more accurately describe the complexities of the human immune system.